Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:collaboratesWith |
gptkb:Mayo_Clinic
gptkb:National_Institutes_of_Health |
| gptkbp:country |
gptkb:United_States
|
| gptkbp:developedBy |
NAD+ boosting therapeutics
|
| gptkbp:focusesOn |
age-related diseases
NAD+ metabolism |
| gptkbp:foundedBy |
gptkb:David_Sinclair
|
| gptkbp:headquartersLocation |
gptkb:Massachusetts
|
| https://www.w3.org/2000/01/rdf-schema#label |
MetroBiotech
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
MIB-626
|
| gptkbp:researchArea |
mitochondrial function
rare diseases metabolic disorders muscle diseases |
| gptkbp:website |
https://www.metrobiotech.com/
|
| gptkbp:bfsParent |
gptkb:David_A._Sinclair
|
| gptkbp:bfsLayer |
7
|